Artificial Intelligence in R&D

Artificial intelligence (AI) can transform how we discover, develop, and deliver therapies. It can help us provide better care at lower cost and empower people to manage their disease.
Monica Wu, Sr. Scientist, US - Hailey Donohue, mRNA, Senior Research Associate, mRNA production, US

Shortening the Diagnostic Journey With AI

Our data science community spans every therapeutic area, with particular focus on cancer, inflammatory conditions, rare blood disorders, rare diseases, vaccines, and neurological disorders.  

At every level of R&D, we’re building scalable data platforms to shorten the diagnostic journey and improve both public health and the standard of care for diseases. 

Illustration of a neuron cell network

Data-Driven Discovery

AI helps us accelerate R&D for patients. To leverage data at all stages of drug discovery, we develop, extend, and apply AI methods including:  

  • deep neural networks and other technologies for target identification 

  • active learning for drug and molecule design

  • graphical models for integrating clinical and molecular data to improve clinical trials. 

Illustration of DNA technology

Real-World Evidence (Rwe)

We collaborate across disciplines to discover and validate digital biomarkers of disease. We use AI, bioinformatics, and other methods to find meaningful patterns in complex, multi-dimensional datasets.

For example, to anticipate flare-ups in patients with some conditions, we can use AI and data from smart devices, wearables, electronic health records, genomics, proteomics, and real-time environmental measures.

Automatization lab mRNA equipment - Marcy-L'Etoile - France

Open Science and Collaboration

Open science helps us do more. Through Open Targets, we work with academic and industry partners to improve drug-target identification and prioritization. And in partnership with small- and medium-sized enterprises, we identify new targets, mine RWE to gain new insights into disease drivers, and use large datasets to build disease models while preserving privacy. 

Follow the Science

AI helps our teams discover digital biomarkers for disease, zero in on new targets, and even redefine diseases. 

AI Goes Industrial

How Digital Technologies Are Accelerating Our Drug Discovery and Development Process

Partner Spotlight: Owkin and Sanofi Embrace the “Golden Era” of Precision Medicine With AI

Page updated September 2023 

MAT-GLB-2204681 v1.0 09/2023